Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Leuprorelin acetate

EU orphan designation number: EU/3/16/1821   
Active ingredient: Leuprorelin acetate
Indication: Treatment of congenital hypogonadotropic hypogonadism
Sponsor: Stichting Centre for Human Drug Research (CHDR)
Zernikedreef 8, Leiden 2333 CL, Nederland

  

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/01/2017 Orphan designation EMA/OD/097/16 (2017)225 of 12/01/2017